SCHEMBL6834211

SCHEMBL6834211

Cc1sc(C(=O)Nc2ccc(C#N)cc2C(=O)O)cc1S(=O)(=O)Nc1ccc2c(c1)CCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 0.40
NPSR1 Q6W5P4 3/20 0.40
SMN1; SMN2 Q16637 7/20 0.40
ALDH1A1 P00352 4/20 0.40
HTT P42858 4/20 0.40
MAPT P10636 4/20 0.40
POLB P06746 3/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
ALB P02768 1/20 0.39
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
DRD3 P35462 1/20 0.39
HTR6 P50406 1/20 0.39
THRB P10828 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
MCL1 Q07820 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6350261 0.81 ALB (0.55) LMNASMN1; SMN2ALDH1A1HTTMAPT
SCHEMBL7066732 0.79 MEN1 (0.44) ALDH1A1KDM4EALBMEN1KMT2A
SCHEMBL6349405 0.79 MAPT (0.56) LMNASMN1; SMN2ALDH1A1HTTMAPT
SCHEMBL6932502 0.78 ALB (0.54) LMNASMN1; SMN2ALDH1A1MAPTPOLB
SCHEMBL6834232 0.78 PPARG (0.53) MAPTPOLBKDM4EALBMEN1
SCHEMBL6930797 0.77 ALB (0.53) LMNASMN1; SMN2ALDH1A1MAPTPOLB
SCHEMBL7064764 0.75 ALB (0.46) ALDH1A1HTTPOLBALBMEN1
SCHEMBL6833721 0.75 MCOLN3 (0.44) LMNANPSR1SMN1; SMN2ALDH1A1HTT
SCHEMBL6835846 0.74 ALB (0.66) LMNASMN1; SMN2ALDH1A1HTTMAPT
SCHEMBL6830277 0.74 ALB (0.45) LMNANPSR1SMN1; SMN2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 LMNA 3376/4885NPSR1 2992/4885SMN1; SMN2 2022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.